{"id":186,"date":"2005-09-13T20:43:15","date_gmt":"2005-09-14T00:43:15","guid":{"rendered":"http:\/\/gillesenvrac.ca\/carnet\/?p=186"},"modified":"2022-02-08T13:17:08","modified_gmt":"2022-02-08T18:17:08","slug":"lacces-libre-une-condition","status":"publish","type":"post","link":"https:\/\/gillesenvrac.ca\/carnet\/2005\/09\/lacces-libre-une-condition\/","title":{"rendered":"l&#039;acc\u00e8s libre : une condition"},"content":{"rendered":"<blockquote dir=\"ltr\" style=\"margin-right: 0px\"><p><a href=\"http:\/\/news.bbc.co.uk\/1\/hi\/education\/4224072.stm\" target=\"_blank\" rel=\"noopener\">Call for Free Access to Research , BBC News<\/a>&nbsp;More on what is becoming a pervasive trend, the call for free access to publicly funded research. \u00ab\u00a0The eight UK research councils, which control most of the public funding, have proposed making free access a condition of getting grants.\u00a0\u00bb&nbsp; [<a href=\"http:\/\/www.downes.ca\/news\/OLDaily.htm\">OLDaily<\/a>]<\/p><\/blockquote>\n<p>Huit conseils de recherche du Royaume-Uni, responsables de la plus grande part du financement de la recherche, envisagent de faire de l&rsquo;accessibilit\u00e9 gratuite&nbsp;aux r\u00e9sultats de&nbsp;ces recherches une condition de financement. Enfin ! Le financement public devrait \u00eatre conditionnel \u00e0 l&rsquo;acc\u00e8s du public aux r\u00e9sultats.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Call for Free Access to Research , BBC News&nbsp;More on what is becoming a pervasive trend, the call for free access to publicly funded research. \u00ab\u00a0The eight UK research councils, which control most of the public funding, have proposed making free access a condition of getting grants.\u00a0\u00bb&nbsp; [OLDaily] Huit conseils de recherche du Royaume-Uni, responsables &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/gillesenvrac.ca\/carnet\/2005\/09\/lacces-libre-une-condition\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> de &laquo;&nbsp;l&#039;acc\u00e8s libre : une condition&nbsp;&raquo;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"atmosphere_disabled":false,"atmosphere_custom_text":"","_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[39,26,36],"class_list":["post-186","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-acces-libre","tag-polis","tag-techno"],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":630,"url":"https:\/\/gillesenvrac.ca\/carnet\/2007\/09\/subventions-acces-libre-aux-resultats\/","url_meta":{"origin":186,"position":0},"title":"subventions = acc\u00e8s libre aux r\u00e9sultats","author":"Gilles Beauchamp","date":"6 septembre 2007","format":false,"excerpt":"CIHR Introduces New Open Access Policy: \"The Canadian Institute for Health Research has announced, formally, its Open Access mandate for all funded research. Peter Suber has coverage. Stevan Harnad notes that it makes CIHR the 31st organization worldwide to do so. It's worth noting that this amounts to 'five percent\u2026","rel":"","context":"Dans \"droits d'auteur\"","block_context":{"text":"droits d'auteur","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/droits-dauteur\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1806,"url":"https:\/\/gillesenvrac.ca\/carnet\/2009\/01\/acces-libre-a-oxford\/","url_meta":{"origin":186,"position":1},"title":"acc\u00e8s libre \u00e0 Oxford","author":"Gilles Beauchamp","date":"28 janvier 2009","format":false,"excerpt":"International Journal of Epidemiology Journal of Public Health European Journal of Public Health Health Education Research British Journal of Social Work Analysis Mind Social History of Medicine Age and Ageing Je ne sais si \u00e7a durera longtemps... mais j'ai pu obtenir tous les articles que j'ai voulus de ces revues,\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":625,"url":"https:\/\/gillesenvrac.ca\/carnet\/2007\/09\/entre-nous\/","url_meta":{"origin":186,"position":2},"title":"entre nous","author":"Gilles Beauchamp","date":"1 septembre 2007","format":false,"excerpt":"Ne le dites \u00e0 personne, c'est juste entre nous : plusieurs dizaines de revues publi\u00e9es par la maison Sage Journals Online, sont d'acc\u00e8s libre durant le mois de septembre. Tous les articles, les archives, tout ! Yessss ! Oh, voici l'adresse o\u00f9 vous n'avez qu'\u00e0 vous inscrire: free online full\u2026","rel":"","context":"Dans \"apprendre\"","block_context":{"text":"apprendre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/apprendre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4288,"url":"https:\/\/gillesenvrac.ca\/carnet\/2012\/10\/open-access-inistgate\/","url_meta":{"origin":186,"position":3},"title":"Open Access, #Inistgate","author":"Gilles Beauchamp","date":"27 octobre 2012","format":false,"excerpt":"Un d\u00e9bat (#Inistgate) lanc\u00e9 par Olivier, chercheur, enseignant et blogueur (affordance), d\u00e9non\u00e7ant la revente de certaines de ses publications par un service public fran\u00e7ais, alors que ces m\u00eames textes sont en acc\u00e8s libre ailleurs sur le web. Belle plume que celle d'Olivier\u00a0Ertzscheid. La question de l'acc\u00e8s libre aux publications scientifiques\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1134,"url":"https:\/\/gillesenvrac.ca\/carnet\/2008\/10\/la-journee-de-lacces-libre\/","url_meta":{"origin":186,"position":4},"title":"la journ\u00e9e de l&#039;acc\u00e8s libre (Open Access Day)","author":"Gilles Beauchamp","date":"14 octobre 2008","format":false,"excerpt":"Aujourd'hui nous ne c\u00e9l\u00e9brons pas seulement la fin de la campagne \u00e9lectorale f\u00e9d\u00e9rale mais bien la premi\u00e8re journ\u00e9e internationale de l'acc\u00e8s libre (Open Access Day). Pour un acc\u00e8s libre \u00e0 l'information, \u00e0 la science. C'est aussi (et c'est la raison justifiant le choix de ce jour, je crois) le 5e\u2026","rel":"","context":"Dans \"acc\u00e8s libre\"","block_context":{"text":"acc\u00e8s libre","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/acces-libre\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3089,"url":"https:\/\/gillesenvrac.ca\/carnet\/2009\/12\/tamiflu\/","url_meta":{"origin":186,"position":5},"title":"Tamiflu et l&#039;acc\u00e8s aux donn\u00e9es de recherche","author":"Gilles Beauchamp","date":"22 d\u00e9cembre 2009","format":false,"excerpt":"Complications: tracking down the data on oseltamivir. Cet article (en acc\u00e8s libre) de la revue British Medical Journal raconte dans le d\u00e9tail les difficult\u00e9s \u00e0 obtenir des r\u00e9ponses de la part de la pharmaceutique Roche, \u00e0 propos d'un ensemble de recherches suppos\u00e9es confirmer la pertinence et l'efficacit\u00e9 du Tamiflu (oseltamivir,\u2026","rel":"","context":"Dans \"sant\u00e9 publique\"","block_context":{"text":"sant\u00e9 publique","link":"https:\/\/gillesenvrac.ca\/carnet\/tag\/sante-publique\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts\/186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/comments?post=186"}],"version-history":[{"count":0,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/posts\/186\/revisions"}],"wp:attachment":[{"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/media?parent=186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/categories?post=186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gillesenvrac.ca\/carnet\/wp-json\/wp\/v2\/tags?post=186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}